Werewolf Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Werewolf Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2024.
  • Werewolf Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 44.6M shares, a 23.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 44.6M +8.37M +23.1% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 43.7M +8.04M +22.6% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 43.5M +8.18M +23.2% Apr 29, 2024 10-Q 2024-05-03
Q3 2023 36.2M +5.45M +17.7% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 35.7M +6.13M +20.8% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 35.3M +7.63M +27.6% Mar 17, 2023 10-K 2023-03-23
Q3 2022 30.7M +3.17M +11.5% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 29.5M +1.96M +7.12% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 27.7M Mar 18, 2022 10-K 2022-03-24
Q3 2021 27.6M Nov 5, 2021 10-Q 2021-11-10
Q2 2021 27.6M Jun 4, 2021 10-Q 2021-06-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.